Tradestie Institutional Equity Comparison Engine

KTWO vs CNMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CNMD Overall Edge

CNMD Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CONMED Corporation (CNMD) driven by superior Valuation, Growth & Margin, Options & Structure while KTWO counters with relative strength in Momentum & Technical. Fundamentally, KTWO trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus CNMD at 9.8x Forward P/E and 10.2% operating margin (-0.7% YoY). In options structure, KTWO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNMD sits in CONSOLIDATION (2nd %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CNMD
KTWO N/M vs CNMD 9.8x Fwd P/E
Growth & Margin Winner CNMD
Op Margin N/A vs 10.2% ยท YoY N/A vs -0.7%
Momentum & Technical Winner KTWO
1Y +2.5% vs +14.9% ยท 52W Pos 97% vs 65%
Options & Structure Winner CNMD
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (2nd %ile IV)
KTWO US Equity
KTWO
Institutional Equity
$10.12
-0.1% 1D
Market Cap N/A
1M Return +0.2%
1Y Return +2.53%
Forward P/E N/M
Unified AI Score
55.8 / 100 HOLD
Tech 66.0 Fund 57.0 Flow 50.0 Mom 50.0
CNMD NYSE
CONMED Corporation
Electromedical & Electrotherapeutic Apparatus
$46.56
+0.39% 1D
Market Cap $1.4B
1M Return -5.83%
1Y Return +14.93%
Forward P/E 9.8x
Unified AI Score
49.1 / 100 HOLD
Tech 34.0 Fund 50.0 Flow 65.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: KTWO +2.53% CNMD +14.93% Spread: +1.66 pp (KTWO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
KTWO TTM Op. Margin: N/A CNMD TTM Op. Margin: 10.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on KTWO vs CNMD. Trailing 12-month operating profitability (KTWO N/A vs CNMD 10.2%) and valuation multiples (KTWO N/M vs CNMD 9.8x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: KTWO (3) vs CNMD (7)
Institutional Metric KTWO CNMD Criterion Row Winner
Market Capitalization Scale N/A $1.4B Larger Scale CNMD
Trailing P/E Ratio Valuation N/M 19.2x Lower Multiple CNMD
Forward P/E Ratio Valuation N/M 9.8x Lower Multiple CNMD
Revenue Growth (YoY) Growth N/A -0.7% Higher Growth CNMD
Operating Margin (TTM) Profitability N/A 10.2% Higher Margin CNMD
Net Profit Margin Profitability N/A 5.4% Higher Margin CNMD
Return on Equity (ROE) Capital Efficiency N/A 7.1% Higher ROE CNMD
52-Week Range Position Momentum 97% ($10โ€“$10) 65% ($31โ€“$55) Stronger Trend KTWO
Beta / 30D Volatility Risk Regime 0.02ฮฒ ยท 4% Vol 0.82ฮฒ ยท 58% Vol Lower Realized Risk KTWO
Unified Institutional Score Composite Signal 55.8 / 100 (HOLD) 49.1 / 100 (HOLD) Higher Composite KTWO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full KTWO vs CNMD Buy Guide
KTWO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live KTWO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNMD CONSOLIDATION
78d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 2nd %ile
IV Regime Compressed (<25th %ile)
Live CNMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither KTWO nor CNMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.